Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer’s disease mice

Journal of Neuroscience

Volumn 35, Issue 17, 2015, Pages 6893-6902

  Chakroborty, Shreaya ^a   Kim, Joyce ^b   Schneider, Corinne ^b   West, Anthony R ^a   Stutzmann, Grace E ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Homeostasis; Nitric oxide; Ryanodine receptor; Synaptic depression; Synaptic plasticity

Indexed keywords

AXIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NESTIN; WNT3A PROTEIN; AMYLOID PRECURSOR PROTEIN; ENZYME INHIBITOR; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; PRESENILIN 1; PSEN1 PROTEIN, HUMAN; RYANODINE RECEPTOR; TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DENTATE GYRUS; FEEDBACK SYSTEM; GLIA CELL; GRANULE CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ALZHEIMER DISEASE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; METABOLISM; NERVE CELL PLASTICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IN VITRO TECHNIQUES; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; PRESENILIN-1; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; S-NITROSO-N-ACETYLPENICILLAMINE; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84929347124     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4002-14.2015     Document Type: Article

References (55)

1. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10:S18-S25. CrossRef Medline
2. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31:454-463. CrossRef Medline
3. Boehning D, Snyder SH (2003) Novel neural modulators. Annu Rev Neurosci 26:105-131. CrossRef Medline
4. Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE (2012) Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 33:1001.el-1001.el6. CrossRef Medline
5. Chakroborty S, Stutzmann GE (2011) Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction. Sci China Life Sci 54:752-762. CrossRef Medline
6. Chakroborty S, Goussakov I, Miller MB, Stutzmann GE (2009) Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J Neurosci 29:9458-9470. CrossRef Medline
7. Chakroborty S, Kim J, Schneider C, Jacobson C, Molgó J, Stutzmann GE (2012a) Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. J Neurosci 32:8341-8353. CrossRef Medline
8. Chakroborty S, Briggs C, Miller MB, Goussakov I, Schneider C, Kim J, Wicks J, Richardson JC, Conklin V, Cameransi BG, Stutzmann GE (2012b) Stabilizing ER Ca2 + channel function as an early preventative strategy for Alzheimer's disease. PloS One 7:e52056. CrossRef Medline
9. Cheung ZH, Ip NY (2012) Cdk5: a multifaceted kinase in neurodegenera-tive diseases. Trends Cell Biol 22:169-175. CrossRef Medline
10. Colton CA, Vitek MP, Wink DA, Xu Q, Cantillana V, Previti ML, Van Nostrand WE, Weinberg B, Dawson H (2006) NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103:12867-12872. CrossRef Medline
11. Colton CA, Wilcock DM, Wink DA, Davis J, Van Nostrand WE, Vitek MP (2008) The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J Alzheimers Dis 15:571-587. Medline
12. Cummings JA, Mulkey RM, Nicoll RA, Malenka RC (1996) Ca2 + signaling requirements for long-term depression in the hippocampus. Neuron 16: 825-833. CrossRef Medline
13. Davies SN, Lester RA, Reymann KG, Collingridge GL (1989) Temporally distinct pre-and post-synaptic mechanisms maintain long-term potentiation. Nature 338:500-503. CrossRef Medline
14. Fioravante D, Regehr WG (2011) Short-term forms of presynaptic plasticity. Curr Opin Neurobiol 21:269-274. CrossRef Medline
15. Fitzjohn SM, Collingridge GL (2002) Calcium stores and synaptic plasticity. Cell Calcium 32:405-411. CrossRef Medline
16. Frey U, Huang YY, Kandel ER (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260:1661-1664. CrossRef Medline
17. Garthwaite J (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:2783-2802. CrossRef Medline
18. Goussakov I, Miller MB, Stutzmann GE (2010) NMDA-mediated Ca(2 +) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice. J Neurosci 30:12128-12137. CrossRef Medline
19. Hatahet F, Ruddock LW (2009) Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal 11:2807-2850. CrossRef Medline
20. Hyman BT, Marzloff K, Wenniger JJ, Dawson TM, Bredt DS, Snyder SH (1992) Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann Neurol 32:818-820. CrossRef Medline
21. Kakizawa S, Yamazawa T, Chen Y, Ito A, Murayama T, Oyamada H, Kure-bayashi N, Sato O, Watanabe M, Mori N, Oguchi K, Sakurai T, Takeshima H, Saito N, lino M (2012) Nitric oxide-induced calcium release via ryanodine receptors regulates neuronal function. EMBO J 31:417-428. CrossRef Medline
22. Kakizawa S, Yamazawa T, lino M (2013) Nitric oxide-induced calcium release: activation of type 1 ryanodine receptor by endogenous nitric oxide. Channels 7:1-5. CrossRef Medline
23. Kim WK, Choi YB, Rayudu PV, Das P, Asaad W, Arnelle DR, Stamler JS, Lipton SA (1999) Attenuation of NMD A receptor activity and neurotoxicity by nitroxyl anion, NO. Neuron 24:461-469. CrossRef Medline
24. Knobloch M, Mansuy IM (2008) Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 37:73-82. CrossRef Medline
25. Law A, Gauthier S, Quirion R (2001) Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 35:73-96. CrossRef Medline
26. Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119:873-887. CrossRef Medline
27. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotec-tive and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632. CrossRef Medline
28. Luth HJ, Munch G, Arendt T (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 953:135-143. CrossRef Medline
29. Meffert MK, Haley JE, Schuman EM, Schulman H, Madison DV (1994) Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 13:1225-1233. CrossRef Medline
30. Müller M, Cardenas C, Mei L, Cheung KH, Foskett JK (2011) Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling. Proc Natl Acad Sci U S A 108:13293-13298. CrossRef
31. Nakamura T, Tu S, Akhtar MW, Sunico CR, Okamoto S, Lipton SA (2013) Aberrant protein s-nitrosylation in neurodegenerative diseases. Neuron 78:596-614. CrossRef Medline
32. Nisticò R, Cavallucci V, Piccinin S, Macrì S, Pignatelli M, Mehdawy B, Blan-dini F, Laviola G, Lauro D, Mercuri NB, D'Amelio M (2012) Insulin receptor beta-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory. Neuromolecular Med 14:262-269. CrossRef Medline
33. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Mether-ate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421. CrossRef Medline
34. Oulès B, Del Prete D, Greco B, Zhang X, Lauritzen I, Sevalle J, Moreno S, Paterlini-Bréchot P, Trebak M, Checler F, Benfenati F, Chami M (2012) Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci 32:11820-11834. CrossRef Medline
35. Palmer ZJ, Duncan RR, Johnson JR, Lian LY, Mello LV, Booth D, Barclay JW, Graham ME, Burgoyne RD, Prior IA, Morgan A (2008) S-nitrosylation of syntaxin 1 at Cys(145) is a regulatory switch controlling Muncl8-1 binding. Biochem J 413:479-491. CrossRef Medline
36. Palop JJ, Mucke L (2010a) Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin? Neuromolecular Med 12:48-55. CrossRef Medline
37. Palop JJ, Mucke L (2010b) Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 13:812-818. CrossRef Medline
38. Peng J, Liang G, Inan S, Wu Z, Joseph DJ, Meng Q, Peng Y, Eckenhoff MF, Wei H (2012) Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. Neurosci Lett 516:274-279. CrossRef Medline
39. Qu J, Nakamura T, Cao G, Holland EA, McKercher SR, Lipton SA (2011) S-nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. Proc Natl Acad Sci U S A 108:14330-14335. CrossRef Medline
40. Ratnayaka A, Marra V, Bush D, Burden JJ, Branco T, Staras K (2012) Recruitment of resting vesicles into recycling pools supports NMDA receptor-dependent synaptic potentiation in cultured hippocampal neurons. J Physiol 590:1585-1597. CrossRef Medline
41. Raymond CR, Redman SJ (2006) Spatial segregation of neuronal calcium signals encodes different forms of LTP in rat hippocampus. J Physiol 570:97-111. CrossRef Medline
42. Reyes-Harde M, Empson R, Potter BV, Galione A, Stanton PK (1999) Evidence of a role for cyclic ADP-ribose in long-term synaptic depression in hippocampus. Proc Natl Acad Sci U S A 96:4061-4066. CrossRef Medline
43. Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ (2013) Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol 12:105-118. CrossRef Medline
44. Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172-188. CrossRef Medline
45. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791. CrossRef Medline
46. Selvakumar B, Jenkins MA, Hussain NK, Huganir RL, Traynelis SF, Snyder SH (2013) S-nitrosylation of AMP A receptor GluAl regulates phosphorylation, single-channel conductance, and endocytosis. Proc Natl Acad Sci U S A 110:1077-1082. CrossRef Medline
47. Shilling D, Muller M, Takano H, Mak DO, Abel T, Coulter DA, Foskett JK (2014) Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis. J Neurosci 34:6910-6923. CrossRef Medline
48. Stanton PK, Winterer J, Zhang XL, Müller W (2005) Imaging LTP of presynaptic release of FM1-43 from the rapidly recycling vesicle pool of Schaffer collateral-CA1 synapses in rat hippocampal slices. Eur J Neurosci 22:2451-2461. CrossRef Medline
49. Steinert JR, Chernova T, Forsythe ID (2010) Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 16:435-452. CrossRef Medline
50. Stutzmann GE (2007) The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"? Neuroscientist 13:546-559. CrossRef Medline
51. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441:513-517. CrossRef Medline
52. Wilcock DM, Lewis MR, Van Nostrand WE, Davis J, Previti ML, Ghark-holonarehe N, Vitek MP, Colton CA (2008) Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. J Neurosci 28:1537-1545. CrossRef Medline
53. Zhao QF, Yu JT, Tan L (2015) S-Nitrosylation in Alzheimer's disease. Mol Neurobiol 51:268-280. CrossRef Medline
54. Ziviani E, Lippi G, Bano D, Munarriz E, Guiducci S, Zoli M, Young KW, Nicotera P (2011) Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. EMBO J 30:194-204. CrossRef Medline
55. Zucker RS, Regehr WG (2002) Short-term synaptic plasticity. Annu Rev Physiol 64:355-405. CrossRef Medline